received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma
Also in September 2025, FDA established a Green List Import Alert (66-80) to help stop GLP-1 APIs that have potential quality concerns from entering the U.S
Unlike the jittery energy from caffeine, this is a natural, sustained vitality because your cells get the fuel they need to function properly
In the group of patients that did not have surgery the researchers reported that: approximately one-third of patients reported improvement, approximately 50% reported no change in symptoms, and approximately 10% to 20% of patients reported that their back pain, leg pain, and walking were worse. Doctors question spinal stenosis surgery Many of the patients we see are looking for a an alternative to spinal surgery